Perimenopause is the new buzzword in the business of women’s health
Sarah Todd, Stat News
AstraZeneca Nexium
A group of consumers who purchased Nexium, a heartburn medication, in Massachusetts since March 2001 filed a class-action lawsuit against AstraZeneca. They claimed that the pharmaceutical company deceptively marketed the medication as superior to its other heartburn drugs so that consumers would buy the more expensive Nexium. In October 2012, AstraZeneca agreed to settle the lawsuit but the terms of the settlement have not yet been announced. (Commonwealth Care Alliance v. AstraZeneca Pharmaceuticals L.P., Case No. 05-0269)
The Latest
Will Walmart Ever Take Responsibility for Deception on Its Site?
TINA.org finds more of the same – and then some – from retail giant.
Amazon to Pay $2.5 Billion to Settle Trickery Charges Related to Prime
FTC lawsuit alleged company duped consumers into signing up and then made it hard to cancel.
Memory Defender
Your best defense against deceptive AI? A little research.
Wendy’s Menu Prices on Food-Ordering Apps
The surprising way you may be paying more for delivery.